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Abstract
Background: Membrane proteins are key components in a large spectrum of diverse functions and thus account
for the major proportion of the drug-targeted portion of the genome. From a structural perspective, the α-helical
transmembrane proteins can be categorized into major groups based on the number of transmembrane helices
and these groups are often associated with specific functions. When compared to the well-characterized
seven-transmembrane containing proteins (7TM), other TM groups are less explored and in particular the
4TM group. In this study, we identify the complete 4TM complement from the latest release of the human
genome and assess the 4TM structure group as a whole. We functionally characterize this dataset and evaluate the
resulting groups and ubiquitous functions, and furthermore describe disease and drug target involvement.
Results: We classified 373 proteins, which represents ~7 % of the human membrane proteome, and includes 69 more
proteins than our previous estimate. We have characterized the 4TM dataset based on functional, structural, and/or
evolutionary similarities. Proteins that are involved in transport activity constitute 37 % of the dataset, 23 % are
receptor-related, and 13 % have enzymatic functions. Intriguingly, proteins involved in transport are more than
double the 15 % of transporters in the entire human membrane proteome, which might suggest that the 4TM
topological architecture is more favored for transporting molecules over other functions. Moreover, we found an
interesting exception to the ubiquitous intracellular N- and C-termini localization that is found throughout the
entire membrane proteome and 4TM dataset in the neurotransmitter gated ion channel families. Overall, we estimate
that 58 % of the dataset has a known association to disease conditions with 19 % of the genes possibly involved in
different types of cancer.
Conclusions: We provide here the most robust and updated classification of the 4TM complement of the human
genome as a platform to further understand the characteristics of 4TM functions and to explore pharmacological
opportunities.
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Background
Membrane proteins are essential in several cell processes
and participate in a wide variety of functions, including
playing pivotal roles in signaling pathways, acting as
regulatory elements, functioning as receptors, and also
facilitating the transport of ions and molecules across
the impermeable lipid bilayer [1]. Due to their diverse
and important functional activities, membrane proteins
serve as major targets for pharmaceutical industries [2, 3].
Approximately 20–30 % of most animal proteomes are
transmembrane proteins, which in humans amounts
to ~5500 proteins [4–6]. The preponderance of membrane
proteins attach to the membrane with transmembrane α-
helices, while the rest are characterized by transmembrane
β-strands forming β-barrels. Previous topology based ana-
lyses of membrane proteins in the human genome have
shown that the largest category of α-helical membrane
proteins is composed of only one transmembrane span-
ning helix, while the second largest category includes
the two transmembrane helix containing proteins [5]
[7]. In particular, several studies point toward a strong
correlation between membrane protein structure and
function and that the number of transmembrane heli-
ces substantially determines what function the protein
carries out [5, 8–10]. Moreover, analyses of structural
topologies of membrane proteomes have shown that
the C-terminus is predominantly located in the inside of
the membrane, as found across humans [5], Escherichia
coli [11] and Saccharomyces cerevisiae [12], and can be en-
gaged in activities such as stabilization, signaling, protein
interactions, and channel gating amongst others [13, 14].
This C-terminus localization is ubiquitous as the majority
of proteins containing odd numbers of helices, such as
those in the large 1TM and 7TM groups, have intracellu-
lar C-termini with N-termini in the extracellular environ-
ment, and protein groups with even helical numbers have
a greater amount of both termini located intracellularly.
Our earlier complete curation of the membrane proteome
in the human genome showed that certain membrane
topologies are more common for specific functions
such as enzymatic activity, receptors, and transporters
[5]. For example, the majority of receptors fall into two
major categories: those that contain either one transmem-
brane helix (TM), or the well-studied 7TM G protein-
coupled receptor (GPCR) group [15–17] which composes
67 % of human receptors [5]. This means that receptors
have a greater number of their N-termini in the extracellu-
lar environment, which functions in activities such as pro-
tein interactions, protein targeting, and signaling [18].
Transporters, another well-researched group, tend to have
six or more membrane-spanning helices, such as the solute
carriers (SLC) that contain 10–14TM [19]. However, mem-
brane bound enzymes generally contain fewer helices and
they largely fall within 1TM or 2TM containing proteins.
Among these TM families that are categorized by the
number of α-helices that span the membrane, the four-
transmembrane helix containing proteins are characterized
by an array of protein families, such as the neurotransmitter
gated ion channels, claudins, connexins, and tetraspanins,
that display large degrees of diversity in their functions.
Neurotransmitter gated ion channels (NGIC) mediate a
rapid transmission of signals at chemical synapses and are a
heavily investigated group that act as both receptors and
transporters [20]. They have four evolutionarily and struc-
turally related 4TM families that include 45 members [21]
plus one more family consisting of one gene, zinc activated
ligand-gated ion channel (ZACN) [22]. Claudins are an-
other major 4TM family and are one of the main structural
components of tight junctions and mediate cell-cell adhe-
sion. There are currently 27 mammalian claudin members
that are found solely in epithelial cells. [23]. They contain
the PMP22_Claudin domain (PF00822) which is a member
of the Transporter superfamily clan, as well as two con-
served cysteine residues in extracellular loop one, and most
claudins contain a PDZ binding motif at the C-terminus
position [24]. Connexins, which are also members of the
Transporter superfamily clan, have been extensively studied
as they are the structural components of gap junctions,
which are involved in cell-cell communication. There
are 21 different connexin proteins described by several
conserved features: a four membrane-spanning domain
(PF00029) and a conserved three-cysteine residue domain
(PF10582) found on each of the two extracellular loops.
And finally, the Tetraspanins include 33 members in
which some members have a wide and abundant distribu-
tion throughout tissues and others are more selectively
expressed [25]. These ‘true’ tetraspanins (to differentiate
from proteins with 4TMs that can also be called tetra-
spanins) contain the tetraspanin functional domain
(PF00335), which is a member of the Tetraspanin-like
clan, as well as a conserved CCG motif with 4–6 conserved
extracellular cysteine residues [26].
Within these larger protein families, selected proteins
have been well characterized, however there still remain
many 4TM proteins that have yet to be fully classified.
To the best of our knowledge, the complete complement
of four-transmembrane helical containing proteins has
not been characterized before in any vertebrate genome,
and curation of the 4TM component of the human gen-
ome can provide an important basis to understand the
diversity of the important 4TM proteome. First, we aim
to provide a qualitative functional classification of the
complete 4TM dataset screened from the latest release
of the human genome (GRCh38.p3). Second, we sought
to analyze whether there is any correlation between the
topological orientations (N-terminus inside or outside of
the membrane) and their functional activities, that is if
certain topologies are favored for certain functional
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classes. Third, we aim to identify how many of these 4TM
proteins are associated with diseases and how many of
them are potential drug targets.
Here, we present the first complete gene repertoire
and detailed functional classification of the human four
membrane-spanning protein dataset.
Results
Identification and curation of the 4TM dataset
A combination of in silico automatic classification followed
by individual sequence curation was used to analyze
proteins with four membrane-spanning regions (see
Fig. 1: Parts A and B, and Methods section for details).
The initial human proteome contained 93,129 protein
coding sequences, and after excising signal peptides
1,296 4TM sequences were initially predicted using
TOPCONS-single. The predicted dataset was reduced
by selecting the longest sequence length per unique
gene (using ENSEMBL gene identification), re-evaluated by
TOPCONS-single, and the non-redundant dataset includes
555 proteins. This dataset does include proteins that may
have incomplete sequences that do not contain initial and/
or terminal residues; that are possibly false-positive
hits from TOPCONS-single; as well as proteins that
are isoforms and contain incomplete functional domains.
Additionally, the proteins need to be evaluated for an-
notation quality and protein validity, i.e. that they have
recognized protein-coding descriptions with acceptable
transcriptional support.
The predicted proteins were evaluated for validity and
reliability through comparison with the CCDS dataset
and then further manually refined (Fig. 1B). The 4TM
dataset includes 101 sequences identified as fragments.
There are 106 proteins established as isoforms that in-
clude 88 proteins that contain Pfam functional domains
that are cited through literature as containing more than
four helices, indicating the protein has an incomplete
domain and consequently functionality cannot be in-
ferred. Additionally, 15 proteins have been identified
through literature and database resources as suspected
false-positive hits from TOPCONS-single. None of these
proteins are included in the 4TM unambiguous dataset.
Forty additional proteins were manually evaluated and
added to the dataset to include members of known 4TM
protein families (for example, claudins and tetraspanins).
The final dataset includes 373 unambiguous 4TM pro-
teins, representing a single protein product from each
gene. These 373 proteins are categorized into five major
groups based on functional, structural, and/or evolution-
ary similarities: Transporters (66), Enzymes (45), Dual
Fig. 1 (Parts A and B). Automatic and manual classification process. Part 1A: Schematic diagram of the automatic classification process. The first
step in the automatic characterization process included downloading the Homo sapiens proteome from the Genome Reference Consortium
human genome 38 (GRCh38) release with the GenCode annotation information. SignalP standalone was used to assess and excise any signal
peptides. The four membrane-spanning regions were predicted using TOPCONS-single, which comprises five different prediction tools and returns
a consensus decision of the number of transmembrane areas. The longest sequence for each genomic location, or gene, was then selected and
then those sequences were re-evaluated with TOPCONS-single. Uniprot, which is a large comprehensive repository of protein sequences with
both manually curated and automatically generated annotations, was used to download associated annotations for each sequence in the predicted
dataset. Part 1B: Schematic overview of the manual curation process for each individual sequence. The purpose of the individual sequence inspections
was to ensure the 4TM dataset was composed of valid proteins with four membrane-spanning regions so that the function could be inferred and
described. The predicted dataset was evaluated for validity and reliability using the CCDS dataset. The predicted dataset includes proteins that may be
fragments, possible false-positive hits from TOPCONS-single, and protein isoforms that contain incomplete functional domains. The Uniprot annotation
data included information such as whether the sequence was a fragment or not, any associated Pfam functional domains or families, the Transportation
Classification (TC) number, the Enzyme Commission (EC) number, as well as Gene Ontology annotation terms
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Function (47), Receptors (2), and Miscellaneous (213).
The proteins identified as Miscellaneous are further clas-
sified into subgroups with similar functions based on




The Transporter category is the largest functional group
with 66 proteins that are further divided into seven
different classes (Fig. 2). Proteins identified with a
Transport Classification number (TC) are included in
this functional class. The alpha-type channel (TCDB
ID: 1.A.-.-.) is the largest group and contains 26 proteins.
Alpha-type channels transport solutes such as potassium,
calcium, sodium, and chloride ions through transmem-
brane pores or channels via an energy-independent
process [27]. Eight of these proteins function as subunits
in gap junctions, where six are connexins and two are
pannexins. There are two proteins within this group that
are identified as drug targets: B-lymphocyte antigen CD20
[SwissProt: P11836] is involved in the regulation of B-cell
activation and proliferation; and Calcium release-activated
calcium channel protein 1 [SwissProt: Q96D31] which
mediates calcium influx following depletion of calcium
stores [28]. Sixteen genes in the alpha-type channel
proteins are identified in various disease conditions and
several of the most common disorders are displayed in
Fig. 2. For a complete overview of the dataset including
gene-disease associations, see Additional file 1.
Eighteen proteins are identified as auxiliary transport
proteins (8.A.-.-.-) that facilitate transport across mem-
branes but do not directly participate in the transport
process [27]. Eleven of these proteins belong to the
Transporter superfamily clan and six proteins are true
tetraspanins. All eight proteins that belong to the paracellu-
lar channel: claudin tight junction class (1.H.-.-.-) contain
the PMP22_Claudin domain (Pfam family: PF00822) and
are members of the previously described claudin proteins.
Paracellular transport transpires outside of cells and
Fig. 2 The human 4TM Transporter class. The figure shows the 66 proteins of the Transporter class that are further categorized into seven
different subclasses. The Transporter Classification number (TC) is determined by the Transporter Classification Database, which has been
cross-referenced through Uniprot to obtain the TC number associated with the protein. The TC system is specific for membrane transport
proteins and includes both functional and phylogenetic information in the numbering information. The transporter proteins identified as drug
targets and the drug indications are also presented. An updated dataset of all current targeted and potential proteins and genes involved in
drug studies or experimentation was used to identify proteins that are drug targets as well as the drug indications. In addition, the top common
gene-disease associations are displayed for each subgroup, with the number of proteins involved in parenthesis. Three different resources
were used to identify gene-disease associations: the Online Mendelian Inheritance in Man (OMIM) database; the Functional Disease Ontology (FunDO)
resource; and the Jensen Lab Diseases database (see Methods for details). Proteins that participate in transport activity but do not have an associated
TC number are not included in this class, but rather in a subgroup of the Miscellaneous proteins. The number in parenthesis represents the number of
proteins that have been identified in that group
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solutes passively follow concentration gradients or transcel-
lular electrical potentials [27]. Four proteins are identified
as putative transport proteins (9.B.-.-.-) where transport
function has been suggested for them, but evidence is not
yet complete and these proteins will eventually be classified
elsewhere or eliminated [27]. Two of these putative trans-
porters contain the MARVEL domain (PF01284): Occludin
[SwissProt: Q16625] is a member of the tight junction asso-
ciated MARVEL proteins (TAMP) [29] and is involved in
several diseases including cancer and neurologic disorders;
and Synaptophysin [SwissProt: P08247] is involved with
structural functions and in targeting vesicles to the plasma
membrane [30] and is also involved in cancer, Alzheimer’s
disease, schizophrenia, and mental retardation. Four
proteins are porters (2.A.-.-.-) that use a carrier-mediated
process to catalyze solutes through the membrane [27]. P-
P-bond hydrolysis-driven transporters (3.A.-.-.-), which
hydrolyze ATP to drive the active transport of solutes, in-
cludes just one protein [SwissProt: P33897]. Recognized
transporters of unknown biochemical mechanism (9.A.-.-.-)
comprises five proteins, of which three are members of
the Transporter superfamily clan.
Enzymes
The Enzyme class includes 45 proteins with a corre-
sponding Enzyme Commission (EC) number (Fig. 3).
Oxidoreductases (EC 1.-.-.-) that catalyze oxidation/
reduction reactions in which H and O atoms or electrons
are transferred from one substance to another include 12
enzymes. There are varied specific functions within this
group, including iron ion binding and lipid metabolic
processes [28]. Transferases (EC 2.-.-.-) are the largest
enzymatic group with 25 proteins, and 18 of these contain
the zf-DHHC palmitoyltransferase functional domain
(PF01529) which is involved in zinc as well as other ion
binding [31]. While there are 23 mammalian DHHC pro-
teins identified in the membrane proteome [32], only 18 of
them are predicted to have 4TMs. There are two proteins
described as hydrolases (EC 3.-.-.-), which use hydrolysis to
form two products. Three proteins are lyases (EC 4.-.-.-)
and two of these contain the Protein tyrosine phosphatase-
like protein domain (PF04387) which functions in very long
chain fatty acid biosynthesis [31]. All three lyases are in-
volved in a variety of disease conditions. And three proteins
are classified as ligases (EC 6.-.-.-) in which all are involved
as E3 ubiquitin ligases.
Dual functions
Forty-seven proteins are distinguished as having dual
functions as either receptor/transporter (46 proteins) or
enzyme/transporter (1 protein) (Fig. 4). The complete
repertoire of the 4TM neurotransmitter gated ion chan-
nel family, also known as the anionic and cationic cys-
Fig. 3 The human 4TM Enzyme class. The figure displays the 45 proteins identified with an EC number that belong to the Enzyme class. The
enzymes are divided into five groups which correspond to the type of chemical reaction that they catalyze. Uniprot cross-references the ENZYME
nomenclature database and IntEnz (Integrated relational Enzyme database) to obtain the EC number associated with a protein. The single protein
classified as a drug target as well as the drug indications are displayed. The drug target and drug indications were identified through an updated
dataset of all current targeted and potential proteins and genes involved in drug studies or experimentation. Some of the most common gene-
disease associations are also shown for each of the subgroups in the Enzyme class. Three different resources were used to identify gene-disease
associations: the Online Mendelian Inheritance in Man (OMIM) database; the Functional Disease Ontology (FunDO) resource; and the Jensen Lab
Diseases database (see Methods for details). Proteins that are involved in enzymatic activity but do not have an associated EC number are not
included in this class, but rather in a subgroup of the Miscellaneous proteins. The number in parenthesis represents the number of proteins that
have been identified
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loop receptor group, includes all 45 proteins that belong
to four different families as well as the single zinc
activated ligand-gated ion channel protein [SwissProt:
Q401N2]. The four families include gamma-aminobutryic-
acid (GABAA), glycine, 5-hydroxytryptamine-3 (5HT3), and
acetylcholine (nAChR) receptors and each protein contains
the conserved neurotransmitter ligand binding domain
(PF02931) as well as the ion channel domain (PF02932).
All 46 NGIC proteins are described with a TC number
as well as being identified as a receptor. In addition,
these proteins are characterized by extracellular N- and
C-termini. Thirty-five of the proteins are identified as
drug targets which include a range of indications, as
shown in Fig. 4. The common disease conditions include
neurological diseases such as epilepsy, autistic disorder,
schizophrenia, Alzheimer’s disease, various dependencies,
as well as different cancers.
Receptors
The two proteins identified solely as receptors each be-
long to different receptor types. The first receptor is the
high affinity immunoglobin epsilon receptor subunit
beta [SwissProt: Q01362] and is a member of the IgE
receptors, which combine with specific molecular sites
on the surface of B- and T-lymphocytes. This protein is
also identified as a drug target and is used as an anti-
asthmatic agent. The second receptor is the type-1
angiotensin II receptor-associated protein [SwissProt:
Q6RW13] and is a cell surface protein that binds angio-
tensins, which cause vasoconstriction that increases
blood pressure, and activates intracellular changes that
influence cell behavior. The Receptor class was identified
using manual screening with two resources: the Medical
Subject Headings (MeSH) [33] database and IUPHAR/
BPS: Guide to Pharmacy [34].
Fig. 4 Proteins identified in the Dual functions class. The figure shows the 47 proteins identified as having specific dual functions. All of the
neurotransmitter gated ion channel (NGIC) proteins are presented here, which include 46 members that are characterized by being a transporter
and having a TC number (1.A.-.-.-; alpha-type channel) as well as being identified as a receptor. The NGIC are divided into their five different
protein families, and the number of proteins identified as drug targets and the drug indications are presented. In addition, one protein is determined to be
both an enzyme and transporter and the information is presented in the bottom row of the figure. The drug target and drug indications were identified
through an updated dataset of all current targeted and potential proteins and genes involved in drug studies or experimentation. The gene-disease
associations for all NGIC proteins are also displayed. Three different resources were used to identify gene-disease associations: the Online Mendelian
Inheritance in Man (OMIM) database; the Functional Disease Ontology (FunDO) resource; and the Jensen Lab Diseases database (see Methods for
details). The number in parenthesis represents the number of proteins that have been identified
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Miscellaneous
Many of the 213 proteins classified as Miscellaneous are
multi-functional and involved in a variety of activities.
Fourteen of the Miscellaneous proteins have signal pep-
tides predicted and five proteins have extracellular ter-
minal locations predicted. Fig. 5 shows several of the
larger subgroups of proteins with similar functions that
have been categorized using GO terms. The subgroups
are meant to show the broad activities within the dataset
and present some of the main functional tasks and how
many proteins are involved in them. These functional
subgroups can be composed of a single protein family,
for example all 15 proteins associated with gap junctions
are connexins, or be characterized by several different
families, such as the 25 proteins involved in cell adhe-
sion (in which 22 are claudins and 3 are tetraspanins).
Two of the Miscellaneous proteins are identified as
drug targets. One is Gap junction alpha 1 protein [Swis-
sProt: P17302], which is a connexin subunit and plays a
possibly critical role in hearing and in bladder functional
capacity [28]. It is being investigated for use as a wound
healing accelerant [35]. The other identified drug target
is Leukocyte antigen CD37 [SwissProt: P11049] – a tet-
raspanin that is involved in negative regulation of cell
proliferation and positive regulation of immunoglobulin
production, amongst other functions [28]. This protein
is being targeted as a possible anti-neoplastic agent in
cancer treatment.
Uncharacterized proteins
Thirty-two of the Miscellaneous proteins have an
uncharacterized function and twenty-four of these pro-
teins have a recognized Pfam domain. Within the
uncharacterized proteins, there are six interesting clus-
ters of sequences: there are two sets that each have three
members with the same conserved domain (PF04103
and PF05805); three sets of proteins with two members
each that have the same domain (PF05255, PF14967,
and PF10269); and a sixth group with two proteins that
do not contain a conserved domain, but share ~38 % se-
quence similarity and belong to the same protein family.
(See Fig. 6 for details). In addition, there are three pro-
teins that have possible homologue hits through
BLASTP searches and two proteins that have conserved
domains that were identified through the Conserved do-
main database; the Reticulon domain and the Claudin 2
superfamily, which contains the claudins. Several of the
clusters and homologue hits are discussed below, be-
cause while the uncharacterized proteins do not have
any associated function ascribed to them through GO
terms, valuable information was gleaned through litera-
ture searches.
Fig. 5 The functional subgroups of the Miscellaneous class. The graph displays the breakdown of the larger functional subgroups that contain
158 of the 213 proteins that belong to the Miscellaneous class, as well as the remaining 55 proteins under Various functions. The subgroups were
determined by individually examining GO (general) and GO (molecular) terms as well as Pfam domain and protein family descriptions to categorize
proteins with similar functions. Many proteins participate in multiple activities, and the subgroups are meant to highlight some of the main functional tasks
within the dataset and how many proteins are involved with them. The Transport activity column includes the four subgroups transport activity, vesicle
mediated transport, chemotaxis, and channel activity and totals 30 proteins altogether. The Receptor-like activity column includes both the signaling and
regulation subgroups and totals 36 proteins as well
Attwood et al. BMC Genomics  (2016) 17:268 Page 7 of 16
TMEM50A and TMEM50B [SwissProt: O95807 and
P56557] both contain the UPF0220 Pfam domain
(PF05255) and are the sole members of the TMEM50
protein family. TMEM50A is located on chromosome
1p36.11 in the RH gene locus, between the RHD and
RHCE genes, where its position may be linked to RH
haplotypes and contribute to selective pressures regarding
certain RH haplotypes [36, 37]. According to the Gene
Expression Omnibus (GEO) [38], TMEM50A appears
to be highly upregulated in late stage cervical cancer in
comparison to normal cells. In a study that assesses
biomarkers to investigate the etiology of Down syndrome,
TMEM50B was found to be upregulated two fold in Down
syndrome samples compared to normal [39].
TMEM14B [SwissProt: Q9NUH8] is a member of the
TMEM14 protein family which includes TMEM14A,
TMEM14B, TMEM14C, TMEM14D (which is a pseudo-
gene), and TMEM14E, of which TMEM14B and
TMEM14C are predicted as 4TMs. According to a recent
2015 article [40], NMR shows that 4TMs are predicted in
TMEM14A and TMEM14C, but only 3 TMs span the en-
tire membrane. Perhaps this contributes to TMEM14C as
one of the few proteins with the N-terminus predicted to
be located in the extracellular environment. TMEM14A/B
and C are located on chromosome 6 and TMEM14E is
located on chromosome 3. Only one gene, TMEM14C,
has any associated function – heme biosynthetic process
activity; all others have yet to be characterized. However,
in yeast TMEM14A stabilizes the mitochondrial membrane
potential and inhibits retinamide-induced apoptosis [41].
Neither TMEM179 nor TMEM179B [SwissProt: Q6ZVK1
and Q7Z7N9] contain a conserved Pfam domain but
they share ~38 % sequence identity and belong to the
same protein family. No function could be found asso-
ciated with these proteins, however an article from
2009 [42] identifies TMEM179, which is located on
chromosome 14q32.33, as an ‘evolutionary breakpoint’
region. This region is repeat rich and ‘reused’ during
karyotypic evolution in that breakpoint features that
are retained may have predisposed these genomic re-
gions to large scale chromosomal instability.
TMEM203 and TMEM60 [SwissProt: Q969S6 and
Q9H2L4] both contain the Pfam domain TMEM185A
(PF10269), which is also conserved in the proteins
TMEM185A and TMEM185B (neither of these are pre-
dicted as 4TM). This domain has been identified to be in-
volved with the Fragile-X syndrome through the protein
TMEM185A [43], however TMEM203 and TMEM60
share only ~10 % identity to the TMEM185A/B proteins
and ~21 % identity between each other. In a recent
Fig. 6 Uncharacterized proteins. This figure presents the six sets of uncharacterized proteins that have multiple members with the same conserved Pfam
domain or high sequence similarity. In addition, five uncharacterized proteins that have either conserved domains or hits through BLASTP searches are
also shown
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publication, the previously uncharacterized TMEM203
protein was described as an evolutionarily conserved
regulator of intracellular calcium levels that is required
for spermatogenesis [44].
FAM189A1, FAM189B, and TMEM212 [SwissProt:
O60320, P81408, and A6NML5] each contain the CD20
domain (PF04103), which is a member of the Tetraspanin-
like clan. All three are uncharacterized, however FAM189B
has been shown to possibly interact with the WW domain
binding and be involved in protein binding [45]. Addition-
ally, the three proteins TM4SF18, TM4SF19, and TM4SF20
[SwissProt: Q96CE8; Q96DZ7; Q53R12] all contain the
L6_membrane domain (PF05805), which has unknown
functions. However, there are three other proteins in the
TM4SF protein family with the L6 domain and two are
involved in regulation and signaling while the third is a
transporter.
Major Pfam families and clans within 4TM dataset
There are eight major Pfam domain families and clans
within the dataset that contain between 5–81 members
(see Fig. 7): Transport superfamily clan (78 proteins),
Tetraspanin-like clan (53 proteins), Marvel-like clan
(24 proteins), Zinc beta ribbon clan (18 proteins), NGIC
family (46 proteins), Reticulon family (7 proteins), L6-
membrane family (6 proteins), and Got1/Sft2-like family
(5 proteins). The clans are composed of homologous do-
main families and include the unique four-transmembrane
protein families such as claudins, connexins and tetraspa-
nins. The domain families are formed from the collection
of proteins with the same conserved Pfam domain, such
as the 46 members of the NGIC family, and which do not
belong to any clan and thus do not have any identified
homologous sister families.
The largest clan, the Transport superfamily clan,
comprises 78 proteins from six different conserved
Pfam domain families. The six families within this clan
include: the aforementioned connexin domain (PF00029,
21 proteins); PMP22_claudin (PF00822, 37 proteins);
Claudin_2 (PF13903, 10 proteins); L_HGMIC_fpl
(PF10242, 5 proteins); GSG-1 (PF07803, 2 proteins);
and innexin (PF00876, 2 proteins). The predominant
functions include cell adhesion, transporter activity,
regulation, and cell communication via gap junctions.
The Tetraspanin-like clan is the second largest clan
with 53 proteins and is composed of two families: the
‘true’ tetraspanin domain family (PF00335, 33 proteins)
and the CD20 domain family (PF04103, 20 proteins). The
‘true’ tetraspanins are involved in transport activity and
have also been identified as building tetraspanin enriched
domains (TEMs) that facilitate protein scaffolding and as-
sembly of specialized complexes [26]. The other domain
family, CD20, appears to be cell-surface proteins that are
involved in important cell regulation and differentiation
activities, as well as possibly facilitate intracellular protein-
protein interactions [46].
The 24 proteins that contain the MARVEL domain
belong to the Marvel-like clan. Five of the MARVEL
proteins are classified as transporters while others have
shown association with specialized membrane microdo-
mains (rafts) that could be involved in cholesterol-rich
membrane apposition events in cellular processes such
as biogenesis of vesicular transport carriers or tight
junction regulation [47]. The eighteen proteins in the
Zinc beta ribbon clan contain the zf-DHHC domain
Fig. 7 Functional classification breakdown within the 4TM major clans and families. The figure displays the breakdown of how many proteins
within each major clan and family are identified for each functional class, i.e. Transporter, Enzyme, Dual function, Receptor, and Miscellaneous
classes. Approximately 61 % of the dataset is described by these eight clans and families. The number in parenthesis corresponds to the total
number of proteins within that clan or family
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and act as transferases. The 46 members of the NGIC
family has been discussed previously and the seven pro-
teins in the Reticulon family are involved in activities
such as transport and regulation as well as the apop-
totic process, but one of them is also completely
uncharacterized. The last two domain families include
the six proteins of the L6-membrane family in which
several are involved in transport and regulation, how-
ever three of them are also completely uncharacterized,
and the five proteins of the Got/Sft2-like proteins that
function in vesicle mediated transport.
Some members of these homologous families have
been well-studied; however there are others that are still
not fully described. For example, of the 27 members of
the claudin family, only limited functional knowledge is
available on at least 13 of the proteins: Claudins 6, 9, 12,
13, 18, and 20–27 [48]. Additionally, meaningful GO
functional terms are lacking for at least five proteins of
the ‘true’ tetraspanins (Tspan11, Tspan13, Tspan16,
Tspan18, and Tspan19), as well as at least eleven pro-
teins that contain the CD20 domain and are members of
the MS4A protein family which is involved in important
cell regulation and differentiation activities.
Disease-gene and cancer associations and drug targets
There are 215 genes identified with disease conditions.
Various types of cancers, such as lung, colon, breast, and
liver, are the most common diseases identified with 72
genes recognized in association with them. Many of the
genes are described in multiple disease conditions, as
can be expected from the critical functional activities
that membrane proteins participate in. There are 14
genes associated with epilepsy, 13 genes with schizo-
phrenia, and 13 with autism. Conditions involving deaf-
ness are associated with 12 genes; 10 genes are involved
with nicotine dependence; diabetes, Alzheimer’s disease
and alcohol dependence each have 7 genes identified
with them. As NGIC receptors are involved in a plethora
of neurological disease conditions, it is not surprising
that disease conditions such as schizophrenia, autism,
Alzheimer’s and dependence/addiction are heavily repre-
sented. Additional file 1 includes the complete gene-
disease association descriptions. There are 44 proteins
identified as a current targeted or potential protein that
is involved in drug studies or experimentation, with 35
of them identified in the NGIC family.
Topology
In addition to the number of membrane spanning helices,
the orientations of the N- and C-termini are important
factors in determining the functional activity of the pro-
tein. The terminal orientations are usually determined by
the initial insertion of the peptide into the membrane,
however the presence of a signal peptide can influence dif-
ferent orientations. Signal peptides are short sequences of
amino acid residues attached to the N-terminus domain
that target the protein to the membrane and are then
subsequently removed by proteolysis post membrane
insertion. In addition, when using transmembrane pro-
tein prediction methods, it is important to assess and
excise signal peptides from sequences as otherwise they
can be mistaken as transmembrane helices due to the
hydrophobicity of the peptide sequence [49]. The re-
sults of the TOPCONS-single topology predictions for
this dataset include 316 proteins with the N- and C-
termini located within the lumen of the membrane and
57 proteins with the terminals in the outside environment.
The complete NGIC group, which compose virtually all of
the Dual function class with 46 proteins, have the N- and
C-termini located in the extracellular environment. The
extracellular N-terminus is consistent with the other large
receptor groups, i.e., the 1TMs and 7TMs, however the C-
terminal is usually located in the intracellular environment
due to the important activities it is typically involved in,
particularly signaling transduction. Additionally, 40 of the
NGIC proteins are predicted from the SignalP signal pep-
tide prediction software to have signal peptides. In total
there are 60 proteins that are predicted to have signal pep-
tides. As current transmembrane protein prediction
methods are based on classical helical structures, i.e. those
that completely span the membrane, they do not take into
account anomalies such as reentrant loops, short breaks in
helices, and helices that lie along the surface of the
membrane [8]. As mentioned previously with TMEM14C,
this method limitation could possibly affect the topology
prediction. For example, those 11 proteins that have
predicted extracellular orientation (excluding the NGIC
family) might be interesting proteins to study for trans-
membrane structural purposes. Examples of common
structures and topologies for each functional class are
represented in Fig. 8, which highlights conserved fea-
tures and N- and C-terminus orientations found in the
4TM dataset. For example, claudins, tetraspanins, and
connexins categorized in the Miscellaneous class are
shown with the four conserved membrane regions, the
intracellular location of the N- and C-termini, and also
conserved cysteine residues that are often found in the
extracellular loops and are involved in forming disul-
phide bonds.
Discussion
This consensus topology based screening of 4TMs
followed by manual curation presents the most robust
and updated dataset of the 4TM complement of the hu-
man proteome. Our initial screening of the human
proteome predicts 555 sequences with four membrane-
spanning helices and this estimate is comparable with
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the human tissue-based Protein Atlas database that cur-
rently predicts 554 sequences with four-transmembrane
regions [50]. Both of these 4TM prediction datasets
include all protein products (such as isoforms), and
the Protein Atlas database also uses a majority decision
method but with seven different prediction methods based
on the Ensembl gene annotation. Our protein dataset con-
sists of 373 members after manual curation and also
appending 40 selected proteins, which represents 7 % of
the ~5550 human membrane proteome. This dataset con-
tains 69 more predicted proteins that what was previously
estimated in our human membrane proteome, which also
accounted for a single protein product from each gene,
obtained from the IPI human version 3.39 in 2009. The
different number of predicted proteins might be attributed
to our manual curation process, as well as different num-
ber and types of prediction methods and different gene
annotation sources. There are 341 proteins characterized
in the dataset, which amounts to approximately 91 % of
the proteins having an associated description.
Transporters make up the largest category of 4TMs
and consist of 37 % of the dataset, with 17 % identified
solely in the Transporter class, an additional 12 % in the
Dual function category, and 8 % more in the Miscellan-
eous class that are members of subgroups such as trans-
port activity, vesicle mediated transport, channel activity,
and chemotaxis (see Fig. 5). In the entire human mem-
brane proteome [5], transporters compose approximately
15 % of the proteins, which shows that the 4TM dataset
contains more than double that amount proportionally.
And when comparing against the 6TM protein set, an-
other membrane group known to be involved in transport
activity, roughly 30 % of that group of proteins function in
transport. Comparatively, 23 % in total of 4TM proteins
are involved in receptor activity and 13 % function in en-
zymatic activity, which is commensurate to the roughly
25 % of receptors and 10 % of enzymes found in the entire
membrane proteome. This might suggest that the four-
transmembrane topological architecture is more favored
for transporting molecules than over other functions.
Fig. 8 (Parts a, b, c, d, and e). Common topologies and conserved features within the 4TM dataset. Part a The Miscellaneous class includes
proteins that have been characterized into subgroups through similar functional activities. Common features include intracellular termini and
conserved cysteine residues (yellow outlined in red ovals) in the extracellular loops that either engage in forming disulphide bonds (e.g. claudins
and tetraspanins) or interact and form bonds with other proteins (i.e. connexins). Tetraspanins have 4-6 conserved cysteine residues as well as a
conserved CCG (cysteine-cysteine-glycine) motif in the large extracellular loop 2. Part b The example here, MS4A2, is one of the two identified
receptors and a member of the MS4A protein family, in which 16 members are characterized by 4TMs, a CD20 domain, and an in N-terminus. Part
c The Transporter class includes 66 proteins, of which 65 have an in N-terminus and conserved cysteine residues in the extracellular loops are
common. TMEM205 is the sole transporter with the opposite topology, and is interesting due to its use of novel mechanisms in cisplatin
(chemotherapy) resistance [82]. Part d Of the 45 Enzyme class proteins, all except five maintain an N-terminus intracellular location.
ZDHHC-3 is a typical protein of the ZDHHC protein family, characterized by 4TMs, a conserved DHHC domain, and a conserved DPG
(aspartate-proline-glycine) motif as well as a TTxE (threonine-threonine-asparagine-glutamate) motif. Part e The Dual function class contains 47 proteins
and all 46 proteins of the neurotransmitter gated ion channel family (NGIC) are included here. The NGIC family has a long extracellular N-terminus that
contains several important binding sites as well as two conserved cysteine residues that participate in disulphide bonds. The NGIC family is unique in
that it has extracellular N- and C-termini and also has signal peptides predicted in 40 of the proteins
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Intriguingly, in our topology analysis we found an im-
portant exception to the ubiquitous membrane prote-
ome intracellular locale of the C-terminus in the NGIC
group that performs dual functions; all 46 members have
extracellular N- and C-termini. And concomitantly, 40
of the 46 NGIC proteins are predicted to have signal
peptides. It has been shown [8] that the prokaryotic
2TM glutamate receptor is an example of where the
addition of a cleavable signal peptide can influence the
terminal orientations of proteins that originally had a
cytoplasmic N-terminus, particularly with proteins with
a fewer number of transmembrane helices. The addition
of a signal peptide can cause reorientation of the termini
ends through causing the translocation of the N-
terminus to the outside environment. When the signal
peptide is subsequently cleaved, the location of the ter-
minal is in the extracellular region [51]. Additionally, the
NGIC family possesses a long (~200 amino acids) N-
terminus tail which contributes to a stably folded ligand
binding domain [52, 53]. As shown in the 7TM GPCR
families, signal peptides are more common in those pro-
teins that contain those two factors, i.e. a long N tail and
an N-terminus that engages in stabilizing the ligand
binding domain [54, 55]. This set of factors regarding
the signal peptides and terminal orientations are inter-
esting components that could possibly contribute to the
evolution of the NGIC topology orientations.
An interesting aspect of the functional classification of
the 4TM dataset is that 61 % of the proteins can be de-
scribed by 8 large Pfam families or clans, containing a
range from 5 to 81 members. Fig. 7 depicts the eight
clans and domain families and displays the number of
proteins within each functional class for each clan or
family. Furthermore, there are only 12 proteins that do
not contain any type of conserved functional domain, so
up to 97 % of the 4TM dataset contains conserved features
that are found in homologous domains within other pro-
teins. As described in the results, some members of these
homologous families have been well-studied, however
many others have still not been investigated and function
is inferred through homology. Additionally, this evaluation
elucidates six groups (14 proteins) that have uncharacter-
ized functional activity and that share not only conserved
sequence features but also a similar 4TM structure (see
Fig. 6). These groups of proteins indicate interesting
avenues of future investigation.
Overall, we estimate that 58 % of the genes in our
4TM dataset are identified as being involved in various
disease conditions and roughly 19 % of the genes are
possibly involved in different types of cancer. It is interest-
ing to note that proportionally the Transporter class has a
higher percentage of genes that are possibly involved in
cancer, with 29 % of the proteins in that class identified. In
comparison, the Miscellaneous and Enzyme classes both
had 17 % of their proteins identified with cancer. Part of
this might be accounted for by more research on proteins
involved in transport activities. The involvement of 4TM
proteins in different types of cancer and other disease con-
ditions point toward the importance of this less explored
class of transmembrane proteins and it may be possible to
further utilize this class of transmembrane proteins as
drug targets.
Conclusions
In conclusion, we have functionally classified and manually
curated the 4TM complement of the human proteome,
which is characterized by four-transmembrane helices and
the majority of proteins containing conserved N- and C-
termini intracellular location. This examination of the 4TM
structural group and related functions shows the ubiquitous
transport activity that is unique in a membrane group with
such few transmembrane helices. While 4TM proteins are
not necessarily identified as classical receptors and trans-
porters, we show they are still heavily involved in these ac-
tivities as well as cell communication, cell adhesion, and
working as scaffolding and structural elements. This has led
to perhaps an oversight in pharmacological research efforts.
As this detailed characterization of the 4TM dataset and
the associated gene-disease information exhibit, these
proteins participate in a host of important activities and
it is becoming more apparent that they are also involved
in various disease conditions including cancer and neuro-
logical conditions. Further, this dataset highlights particu-
lar 4TM proteins that are waiting to be studied in
connection to diseases and as possible drug targets.
Methods
Automatic prediction
Generating the initial 4TM dataset
A two-step analysis process was used: in silico transmem-
brane prediction (Fig. 1a) followed by manual curation
and classification. The Homo sapiens genome assembly
GRCh38 with genome annotation GenCode v21 transla-
tions was downloaded from GenCode [56] on February
10, 2015. The genome annotation file contained 93,139
gene products from 19,881 protein-coding genes. As
transmembrane protein prediction methods have difficulty
differentiating between N-terminal alpha helices and
cleavable signal peptides, the genome annotation file
was evaluated with a standalone version of SignalP 4.1
software [49]. SignalP uses a neural network based
method to distinguish between N-terminal helices and
signal peptides. The parameters used were: eukaryotic
organism, default minimum signal peptide length of
10aa, the best method was chosen which designated
TM regions might be present, and the default cutoff value
of 0.45. The mature sequences with the signal peptides
excised were then evaluated with TOPCONS-single
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transmembrane prediction web server to assess membrane
topology including the number of membrane-spanning
helices and orientation of the terminal ends [57]. As pre-
diction methods use different algorithms to discriminate
transmembrane helices, the number of alpha helices pre-
dicted by each method varies. One manner to improve the
accuracy in membrane prediction and is to use several
prediction methods and make a consensus or majority
decision regarding topology. TOPCONS-single uses a
consensus decision method that comprises five different
prediction tools: SCAMPI-single [58]; S-TMHMM [59];
MEMSAT 1.0 [60]; HMMTOP [61]; and Phobius [62].
The Benchmark of membrane helix predictions from se-
quence website was used to assess the accuracy of the
methods used in TOPCONS-single, and the percentage
accuracy for which all membrane helices were correctly
predicted for the methods ranged from 56–72 % [63],
which is comparable to the TOPCONS-single published
benchmark results (51–73 %) [57]. The initial membrane
topology was performed using all five prediction methods.
The predicted four-transmembrane sequences were re-
trieved and sorted by gene identification (Ensembl gene
identification) and sequence length. The dataset was re-
duced by retaining the longest sequence per gene from the
predicted sequences. At this juncture, the dataset possibly
includes isoforms of proteins as the predicted 4TM
sequence may not necessarily be the canonical sequence
of that gene. The dataset was then re-evaluated with
TOPCONS-single again to attempt to mitigate false-
positive proteins and obtain as accurate dataset as
possible, and the final non-redundant predicted 4TM
dataset was produced.
Manual curation
Determining the unambiguous 4TM proteins
The manual classification process included four steps,
which are highlighted in Fig. 1B. Universal protein re-
source (Uniprot) [28] was used to access annotation in-
formation on the dataset by using the unique Ensembl
protein identification associated with each protein. Uni-
prot is a large comprehensive repository of protein se-
quences with manually curated as well as automatically
generated associated annotations. For each protein, the
associated UniProt annotations were used in the cur-
ation process: gene name, sequence status, review status,
Consensus Coding Sequence identifier, Transporter Clas-
sification number, Enzyme Commission number, Pfam
domain information, Gene Ontology annotation terms,
and protein family information.
The Uniprot sequence information is derived from
translated sequences that have been submitted to the
International Nucleotide Sequence Database Collabor-
ation (INSDC), which is EMBL-bank, GenBank, and
DDBJ. The canonical sequence is determined from either
the most prevalent, the most similar to orthologous se-
quences, the properties of the amino acid composition, or
in lieu of nothing else, then the longest sequence. The se-
quence status is defined as either complete or fragment, in
which the canonical sequence is missing amino acid resi-
dues, often in the initial or terminal ends. Those protein
sequences identified as fragments were considered invalid
proteins and culled from the dataset. To reduce false-
positive predictions from TOPCONS-single, proteins that
were identified in literature or database sources as having
less than or greater than four-transmembrane segments
were also removed from the dataset.
The initial gene annotation source, GenCode, has ~1050
more protein-coding gene entries than the most conserva-
tive annotation resource, the Consensus Coding Sequence
dataset (CCDS) [64]. Therefore the CCDS identifier was
used to assess the validity of each protein, i.e. that each
has acceptable transcriptional support and recognized
protein-coding annotation. Additionally, the sequence sta-
tus, CCDS identifier, and sequence length were used to
ensure that the predicted protein was the main (or canon-
ical) protein product of the gene and not an isoform.
There are eight predicted proteins in the dataset that do
not have a CCDS identifier associated with them. Five of
these have annotation support through RefSeq [65], Vega
[66], UCSC, and Ensembl [67] and the authors have
chosen to retain them in the dataset. Two genes are iden-
tified as pseudogenes (Gje1 and Cyp2d7) however they ap-
pear to be capable of some functional activity and were
retained in the dataset: while Gje1 does not form func-
tional gap junction channels, it causes enhanced ATP re-
lease from HeLa cells, and with two SNPs Cyp2d7 may
result in an open reading frame with a protein-coding
product [65]. Unc93b1 was discussed in our previous
examination of the membrane proteome [5] and has been
evaluated in literature as having multiple functions [68]
with truncated isoforms and thus could be an important
protein to include.
The functional domains and families for each sequence
were obtained through cross-referencing the Pfam data-
base. The Pfam [69], InterPro [31], and ProSite [70] data-
bases as well as appropriate literature were used to assess
the characteristics and number of transmembrane helices
of each Pfam domain associated with each protein. Pro-
teins that contained a domain that had evidence of more
than four-transmembrane helices, and thus the predicted
4TM protein contained an incomplete functional domain,
were also discarded from the dataset. The remaining pro-
teins compose the 4TM unambiguous dataset.
Classifying the unambiguous 4TM proteins
The Transporter Classification number (TC), Enzyme
Commission number (EC), Gene Ontology (GO) terms,
Pfam domain characteristics, and protein family information
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were used to describe the functions of the unambigu-
ous 4TM dataset and categorize them into appropriate
classes. The Transporter Classification Database [27] is
cross-referenced by Uniprot to provide all TC numbers.
The Transporter Classification system is an IUBMB ap-
proved classification system for membrane transport
proteins that includes both functional and phylogenetic
information. Proteins that had an associated TC number
were classified as Transporters. The Enzyme Commission
number is produced by cross-referencing the ENZYME
nomenclature database [71] and IntEnz (Integrated rela-
tional Enzyme database [72]. If a protein had an associated
EC number, they were categorized as Enzymes. Recep-
tors were determined though manually processing se-
lected proteins through the Medical Subject Headings
(MeSH) [33] and IUPHAR/BPS: Guide to Pharmacy
[34] resources.
To help mitigate possible false-negative hits from
TOPCONS-single that missed true 4TM proteins and to
provide as complete a 4TM protein repertoire as possible,
missing proteins from known protein families (such as
claudins and tetraspanins) were manually explored and
added to ensure the families were fully represented in the
dataset. In total, forty additional proteins were added to
the final dataset that had been identified in literature or
database resources as containing 4TM regions.
Proteins that were not classified as Enzymes, Trans-
porters, Receptors, or Dual Functions were grouped into
the Miscellaneous class. To further describe the miscel-
laneous proteins, GO (general) and GO (molecular)
terms were used to categorize proteins with similar func-
tions into subgroups such as cell adhesion, chemotaxis,
gap junction, enzymatic activity, regulation, etc. The GO
terms are cross-referenced from the GO project, which
aims for a consistent and comprehensive functional an-
notation for gene products across databases [73]. There
were several proteins that did not have any associated
GO terms, but there were Pfam domains that described
the function of the protein. There were also proteins
where even with a conserved Pfam domain the function
of the protein was unknown or uncharacterized. Those
miscellaneous proteins that did not have any described
function were categorized as uncharacterized.
Investigating the uncharacterized proteins
The uncharacterized proteins were further researched
using the National Center for Biotechnology Information
(NCBI) BLASTP [74] resource. BLASTP was used to de-
termine if there were any possible homologues with the
uncharacterized protein. The Non-redundant protein
dataset (nr) was the search dataset and the default pa-
rameters were used including the Blosum 62 substitution
matrix; Word size: 3; and Expectation threshold: 10.
Resulting hits with acceptable scores for investigating
distant homologues were retained: greater than ~25 %
sequence similarity; an E-value between 0 –1e-6; and a
bit score value >50 [75]. In addition, literature searches
through NCBI PubMed were performed on selected
proteins.
Determining gene-disease associations and identifying drug
targets
Three different resources were utilized to investigate
gene-disease associations within the dataset. The Online
Mendelian Inheritance in Man (OMIM) [76] database
was cross-referenced through UniProt and the associated
annotations for each protein were downloaded. OMIM
contains a catalogue of genetic traits and disorders with
referenced overviews on all known Mendelian disorders.
The Functional Disease Ontology (FunDO) [77] resource
incorporates Disease Ontology terms, which identifies
gene-disease associations, but has a simplified vocabulary
list called DOLite to enable more interpretable results
[78]. The DOLite gene-disease mapping file was down-
loaded and gene names within the dataset were searched.
The third resource was the Diseases database [79] which
incorporates disease-gene associations from automatic
text mining, manually curated literature, cancer mutation
data, and genome-wide association studies with evidence
confidence scores for each association [80]. The filtered
(non-redundant) text mining file was downloaded and
searched to identify gene-disease associations within
the dataset.
An updated dataset of all current targeted as well as
potential proteins and genes involved in drug studies or
experimentation was obtained from Rask-Anderson et al.
[35]. This dataset is based on data from DrugBank [81],
which provides extensive drug data and target informa-
tion, and then has been manually curated to create a com-
prehensive non-redundant dataset. Both the proteins and
genes within the unambiguous 4TM dataset were investi-
gated to identify drug targets.
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